Trial intelligence / Profile preview

Comparison of analgesic effects of different doses of esketamine in day surgery

ChiCTR2200062255Phase 4Not yet recruiting

Sponsor
The First Affiliated Hospital of Dalian Medical University
Start
Jul 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of esketamine in postoperative pain (3 arms), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoint: Postoperative pain score. Planned start Jul 2022; status: not yet recruiting.

02

Drugs

esketamine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ChiCTR2200062255.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200062255.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call